Ocular Therapeutix Inc (OCUL)
5.865
+0.84
(+16.83%)
USD |
NASDAQ |
May 02, 16:00
5.99
+0.12
(+2.13%)
After-Hours: 20:00
Ocular Therapeutix Total Long Term Debt (Quarterly): 74.92M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 74.92M |
September 30, 2023 | 73.89M |
June 30, 2023 | 55.37M |
March 31, 2023 | 54.68M |
December 31, 2022 | 54.01M |
September 30, 2022 | 53.34M |
June 30, 2022 | 52.70M |
March 31, 2022 | 52.06M |
December 31, 2021 | 51.44M |
September 30, 2021 | 50.82M |
June 30, 2021 | 50.24M |
March 31, 2021 | 48.02M |
December 31, 2020 | 49.53M |
September 30, 2020 | 48.97M |
June 30, 2020 | 51.47M |
March 31, 2020 | 50.36M |
December 31, 2019 | 49.31M |
September 30, 2019 | 48.10M |
June 30, 2019 | 48.80M |
March 31, 2019 | 47.86M |
Date | Value |
---|---|
December 31, 2018 | 24.79M |
September 30, 2018 | 14.17M |
June 30, 2018 | 15.63M |
March 31, 2018 | 17.08M |
December 31, 2017 | 18.02M |
September 30, 2017 | 17.92M |
June 30, 2017 | 17.82M |
March 31, 2017 | 17.72M |
December 31, 2016 | 15.64M |
September 30, 2016 | 15.55M |
June 30, 2016 | 15.46M |
March 31, 2016 | 15.36M |
December 31, 2015 | 15.27M |
September 30, 2015 | 15.13M |
June 30, 2015 | 15.04M |
March 31, 2015 | 14.95M |
December 31, 2014 | 14.86M |
September 30, 2014 | 14.78M |
June 30, 2014 | 14.68M |
March 31, 2014 | 2.003M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
48.02M
Minimum
Mar 2021
74.92M
Maximum
Dec 2023
53.58M
Average
51.44M
Median
Dec 2021
Total Long Term Debt (Quarterly) Benchmarks
Amgen Inc | 64.61B |
Assertio Holdings Inc | 38.21M |
CytomX Therapeutics Inc | 0.00 |
EyePoint Pharmaceuticals Inc | 0.00 |
Regeneron Pharmaceuticals Inc | 1.983B |